ZSTK474, a novel PI3K inhibitor, modulates human CD14(+) monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis. Xue Z, Li W, Wang H, Huang B, Ge Z, Gu C, Liu Y, Zhang K, Yang J, Han R, et al. J Mol Med (Berl). 2014 May 22. Epub 2014 May 22. PMID: 24844601. Abstract CommentRecommendBookmarkWatch